Safety Alerts & Recalls

What does this mean?

This recall for Temodar 5 mg from was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Temodar 5 mg and are concerned, you should speak to your doctor.

Schering-Plough Products Recalls Single Lot of Temodar (temozolomide capsules), 5 mg

Schering-Plough Products has recalled a single lot of Temodar (temozolomide capsules), 5 mg. Lot number 0HLO008 has been recalled because samples from this lot did not pass the manufacturer's routine tests for impurities and by-products from chemical breakdown over time.

Temodar contains the active ingredient temozolomide capsules and is commonly used in the treatment of specific types of brain tumor. This recall alert only applies to the single lot of Temodar (temozolomide capsules), 5 mg. No other temozolomide capsules products were involved in this recall.

To view the FDA notice about this recall, please visit: more information here

Source: FDA
Publication Date: 2012-05-01
Last Updated: 2012-05-01

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.
Back to Consumer Med Safety